Nanoviricides Inc
(NNVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,424 | -6,212 | -4,073 | -1,842 | -8,564 |
| Depreciation Amortization | 696 | 522 | 347 | 173 | 1,039 |
| Accounts payable and accrued liabilities | 803 | 646 | 694 | 708 | -146 |
| Other Working Capital | 568 | 350 | 654 | 726 | 32 |
| Other Operating Activity | -445 | -436 | -743 | -728 | -138 |
| Operating Cash Flow | $-6,803 | $-5,131 | $-3,121 | $-962 | $-7,776 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -74 | -64 | -58 | -37 | -242 |
| Investing Cash Flow | $-74 | $-64 | $-58 | $-37 | $-242 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,350 | 2,350 | N/A | N/A | N/A |
| Financing Cash Flow | $2,350 | $2,350 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 7,082 | 7,082 | 7,082 | 7,082 | 15,100 |
| End Cash Position | 2,555 | 4,237 | 3,904 | 6,082 | 7,082 |
| Net Cash Flow | $-4,527 | $-2,845 | $-3,178 | $-999 | $-8,018 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,803 | -5,131 | -3,121 | -962 | -7,776 |
| Capital Expenditure | -74 | -64 | -58 | -37 | -242 |
| Free Cash Flow | -6,877 | -5,195 | -3,178 | -1,000 | -8,018 |